Clinical trials
Completed Mucopolysaccharidosis I trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 2 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 4 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genzyme, a Sanofi Company | 9 |
| Masonic Cancer Center, University of Minnesota | 5 |
| ArmaGen, Inc | 4 |
| University of Minnesota | 3 |
| JCR Pharmaceuticals Co., Ltd. | 2 |
| Centre Hospitalier Universitaire de Liege | 1 |
| Children's Hospital Los Angeles | 1 |
| Cinnagen | 1 |
| Duke University | 1 |
| Emory University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mucopolysaccharidosis I | 39 |
| Mucopolysaccharidosis II | 8 |
| Mucopolysaccharidosis VI | 7 |
| Mucopolysaccharidoses | 6 |
| Anemia, Diamond-Blackfan | 5 |
| Adrenoleukodystrophy | 4 |
| Anemia, Sickle Cell | 4 |
| Granulomatous Disease, Chronic | 4 |
| Leukodystrophy, Globoid Cell | 4 |
| Leukodystrophy, Metachromatic | 4 |
Trials
Showing 51 to 39 of 39. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.